Advertisement

Fewer Bleeding Events Seen With Abelacimab Than Rivaroxaban in A-Fib

0

Lower levels of free factor XI and fewer bleeding events seen in patients with atrial fibrillation at moderate-to-high risk for stroke

Perioperative Chemo With FLOT Ups Survival in Resectable Esophageal Cancer

0

Improved survival seen with perioperative chemotherapy with FLOT versus preoperative chemoradiotherapy

FDA Warns Sanofi of Manufacturing Irregularities at Key Facility

0

Agency cites contamination at Massachusetts plant where company makes ingredients used to produce various medicines

FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression

0

Drug is the first and only approved monotherapy for refractory major depressive disorder

Study IDs Signs of Topical Steroid Withdrawal in Atopic Dermatitis

0

The most reported signs were erythema, desquamation, dryness, and oozing affecting the face, neck, and upper extremities

Continuous Glucose Monitoring Can Predict Microvascular Complications in Type 1 Diabetes

0

Time-in-range computed from virtual CGM data predicts retinopathy, neuropathy similarly to glycated hemoglobin data

ART Pregnancies Have Higher Exposure to Teratogenic Medications

0

However, overall prevalence of exposure to teratogenic medicines is low

No Link Seen Between GLP-1 Receptor Agonist Use and Thyroid Cancer

0

Authors say large, multisite study should provide reassurance for short-term risk

Trump Ends Push to Slash Prescription Drug Costs

0
By Carole Tanzer Miller HealthDay Reporter WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- With a sweep of the pen, President Donald Trump has ended a...

Medicare to Negotiate Prices for 15 More Drugs, Including Ozempic

0
By India Edwards HealthDay Reporter WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- Medicare will soon negotiate prices for 15 more drugs as part of an...